Skip to content
  Nominations open · Asian Power Brands and Leaders 2026 · entries close 16 October 2026 Nominate →

Profiles · Innovators

Insilico Medicine

Biotech / Life Sciences · Hong Kong

AI-driven end-to-end drug discovery platform identifying novel targets and designing small molecules.

Why it matters

AI-discovered drugs are now in clinical trials, compressing drug discovery from years to months.

Know a brand or leader like this? Nominate them for Power Brands, Asian Power Brands and Leaders 2026. Entries close 16 October 2026.

Nominate

Editorial profile compiled from public sources. Facts are confirmed with the subject before the profile is expanded, and the subject may request corrections at editorial@thecoverstory.world.

Asia 2026 · entries close 16 October 2026 Nominate